Submission of Matters to a Vote of Security Holders - Form 8-K

Item 5.07.Submission of Matters to a Vote of Security Holders.

Panbela Therapeutics, Inc. (the "Company") held a special meeting of stockholders on May 28, 2024. The following proposals, each as described further in the definitive proxy statement for the meeting filed with the Securities and Exchange Commission on May 6, 2024, were voted upon by the stockholders:

Proposal 1 -Reverse Stock Split

Stockholders approved the amendment to the Company's Amended and Restated Certificate of Incorporation to effect a reverse stock split of our outstanding common stock, par value $0.001 per share, at a reverse stock split ratio ranging from any whole number between 1-for-10 and 1-for-45, subject to and as determined by the Board of Directors, based on the votes listed below:

Proposal 2 -Adjournment

Stockholders approved the adjournment of the special meeting to a later date or dates if necessary to solicit additional proxies if there are insufficient votes at the time of the special meeting to approve Proposal 1 in the absence of quorum, based on the votes listed below:

Although Proposal 2 was approved, adjournment of the special meeting was not necessary or appropriate because a quorum was present and the Company's stockholders approved Proposal 1. The Board has not determined the timing or ratio for a reverse stock split, if any.